Martha J. Glenn, |
Dr. Glenn is a hematologist/oncologist who specializes in treating patients with blood-related cancers such as lymphoma and leukemia. She is a clinical research investigator in these types of cancers at Huntsman Cancer Institute. Her research interests include studying genetic causes of lymphoproliferative disorders. She completed medical school at Columbia University, the Medicine Residency Program at Mount Sinai School of Medicine, and a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center, all in New York City. |
||
Paul J. Shami, MD |
Dr. Paul Shami is a Professor of Medicine in the Division of Medical Oncology at the University of Utah and a Member and Clinical Investigator at the University's Huntsman Cancer Institute (HCI) in Salt Lake City, Utah. He is Board Certified in Internal Medicine, Hematology and Medical Oncology. Dr. Shami was born and raised in Beirut, Lebanon. He attended the American University of Beirut where he obtained a Bachelor of Sciences degree in Chemistry in 1984. He was then accepted at the American University of Beirut School of Medicine where he obtained his Doctor of Medicine degree in 1988. Dr. Shami then came to the United States for his residency in Internal Medicine and a fellowship in Hematology/Oncology at Duke University in Durham, North Carolina. While at Duke he trained in the laboratory of Dr. J. Brice Weinberg, a leader in the field of nitric oxide biology. After 3 years as a member of the Duke faculty, he was recruited in 1997 to the University of Utah School of Medicine. He initially established his research lab at the Salt Lake City Veterans Affairs Medical Center where he was Chief of Hematology/Oncology between 2002 and 2005. In 2004 his lab was moved to the University of Utah. He now sees patients exclusively at the Huntsman Cancer Institute. In his research capacity, Dr. Shami oversees the leukemia program at HCI where he has established the most comprehensive leukemia clinical trials program in the Intermountain West. Because of his expertise and national recognition in the treatment of blood cancers he sits on the Acute Myeloid Leukemia, Chronic Myelogenous Leukemia and Myelodysplastic Syndrome panels of the National Cancer Center Network. NCCN panels develop guidelines that are followed nationally and internationally for the treatment of cancer. Dr. Shami's research efforts focus on the development of new therapies for cancer. In collaboration with a team of chemists (led by Dr. Larry Keefer) at the National Cancer Institute, he has developed a new class of drugs that deliver nitric oxide to cancer cells in a targeted fashion. To lead this effort, he founded JSK Therapeutics Inc. (JSKT), a Utah-based biotech start-up company. Dr. Shami has received multiple grants and significant support from the Leukemia and Lymphoma Society, and the National Cancer Institute. |
||
Michael Deininger, MD, PhD |
Dr. Deininger's clinical interests center on leukemia, myeloproliferative neoplasms and hematopoietic stem cell transplantation. His research focuses on the biology of leukemia and development of molecularly targeted therapies for hematologic malignancies. The major focus of his lab is the molecular basis of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer. They are currently developing biomarker strategies to predict both response and resistance to tyrosine kinase inhibitor therapy. Before joining HCI, Deininger served as chief of the Hematologic Malignancies Section and as leader of the Hematologic Malignancies Program at the Knight Cancer Institute at Oregon Health & Sciences University. He earned his medical degree at the University of Würzburg, Germany, with internship at the Marienhospital Aachen, Germany. He completed his residency in internal medicine as well as a fellowship in hematology/oncology at the Institute of Medical Oncology and Haematology of Nürnberg General Hospital, Germany. After earning his PhD in leukemia biology from Imperial College, London, Deininger completed an additional clinical fellowship in bone marrow transplantation in the Department of Hematology at the University of Leipzig, Germany. |
||
Heather Gilbert, MD |
Dr. Gilbert is a hematologist/oncologist who specializes in treating patients with blood-related cancers such as lymphomas and leukemias. She is especially interested in the biology of lymphomas, particularly mantle cell and T-cell lymphomas. She received her medical degree from the University of Utah. She completed her internal medicine and hematology/oncology training in 2008 at the University of Utah. |
||
Josef T. Prchal, MD |
Dr. Prchal is a hematologist who specializes in treating patients with myeloproliferative disorders such as essential thrombocytosis, polycythemia vera, and myelofibrosis. He is an expert in the areas of erythrocyte enzymology, polycythemias, hemoglobin variants, and thalassemias. He received his medical training at Charles University in the Czech Republic and completed his internal medicine residency and fellowship in hematology at the University of Toronto. Dr. Prchal was then a research fellow at City of Hope National Medical Center. He has had academic appointments at the University of Alabama at Birmingham and Baylor College of Medicine. |
||
Ahmed Halwani, MD |
Dr. Halwani specializes in the treatment of blood-related cancers such as lymphoma and leukemia. His research interests include immunotherapy for hematological malignancies, as well as understanding the interactions between the immune system and cancer. He is certified by the American Board of Allergy and Immunology and the American Board of Internal Medicine. He is board eligible for the American Board of Medical Oncology. He received his medical degree from the American University of Beirut, and completed his residency training in Internal Medicine, as well as a dual fellowship in Allergy and Immunology and Medical Oncology at the University of Iowa Hospital and Clinics, in Iowa City, IA. Dr. Halwani sees patients with lymphoma at Huntsman Cancer Institute. He also attends the Leukemia-Lymphoma clinic at the George E. Whalen Department of Veterans Affairs Medical Center in Salt Lake City. |
||
George M. Rodgers III, |
Dr. Rodgers is a hematologist who studies and treats patients with benign hematological disorders, thrombotic disorders, and bleeding disorders. He completed his residency training at Baylor College of Medicine and did his hematology fellowship at the University of California, San Francisco. He received his MD and PhD in pharmacology at Tulane University. He is board certified in internal medicine and hematology. Dr. Rodgers is the coeditor of Wintrobe's Clinical Hematology. |
||
Charles J. Parker, MD |
Dr. Parker is a hematologist/oncologist who specializes in paroxysmal nocturnal hemoglobinuria as well as myeloproliferative disorders. He received his medical and residency training at the University of North Carolina and completed his hematology/oncology fellowship at Duke University. |
||
Maurizio Zangari, MD |
Dr. Zangari is a hematologist/oncologist who specializes in multiple myeloma and hypercoagulability of cancer. He received his medical training from the University of Padua in Italy. He completed an internship in oncology and ENT at Ospedale Civil de Camposampiero in Mirano, Italy. After completing a fellowship in ENT at The University of Padua, he received Internal Medicine residency training at Wykoff Heights Medical Center in Brooklyn, New York. Zangari then trained at Mount Sinai Hospital in New York for a fellowship in hematology and a fellowship in bone marrow transplantation. |
||
Michael W. Boyer, MD |
Dr. Boyer is a hematologist/oncologist who specializes in bone marrow transplant and hematopoietic stem/progenitor cells transplant. He received his medical degree from Indiana University and completed his residency and fellowship training at the University of Minnesota. |
||
Thai M. Cao, MD |
Dr. Cao is a hematologist/oncologist who specializes in bone marrow transplant and hematopoietic stem/progenitor cells transplant. His research focuses on transplant immunology and tolerance, including graft-versus-host disease. He received his medical degree and residency training at the University of Kansas. He completed a hematology/oncology fellowship and a bone marrow transplant fellowship at Stanford University in 2003. |
||
Michael A. Pulsipher, MD |
Dr. Pulsipher is a hematologist/oncologist who specializes in non-myeloblative bone marrow transplantation, hematopoietic cell transplantation, and hematopoietic cell donor safety. He received his medical education at Stanford University and completed his pediatric residency at Children's Hospital of Philadelphia. Pulsipher then received fellowship training in pediatric hematology/oncology at the Dana Farber Institute. |
||
Schickwann Tsai, MD, PhD |
Tsai is a hematologist/oncologist who specializes in bone marrow transplant and hematopoietic stem/progenitor cells transplant. His research focuses on the regulation of hematopoiesis.He received his medical education at National Taiwan University and completed a PhD in cell biology at Harvard University. He completed his internal medicine internship and residency at University of Texas Health Center and fulfilled his hematology/oncology fellowship training at the University of Washington. | ||
David Gaffney, MD, PhD
|
Dr. Gaffney is a radiation oncologist who specializes in radiotherapeutic management of lymphomas, gynecological cancers, and breast cancers. Gaffney received his PhD in biochemistry and his MD from the Medical College of Wisconsin. He completed his internship at LDS Hospital in Salt Lake City and completed a residency in radiation oncology at the University of Utah School of Medicine. |
||
Lynn Million-Smith, MD
|
Dr. Smith is a radiation oncologist who specializes in radiotherapeutic management of lymphomas, sarcomas, and pediatric tumors. Dr. Smith received her medical degree from the University of Florida in Gainesville followed by a residency in radiation oncology and a fellowship in cancer bioresearch, both at Stanford University Medical Center. |
||
Kris Nelson, MSW, LCSW MD
|
Kris works with leukemia, lymphoma, and urological cancer patients at Huntsman Cancer Institute. She earned a masters degree in social work from the University of Utah in 1989. Kris has more than 20 years of experience providing individual, couples, family, and group psychotherapy at the Salt Lake Department of Veterans Affairs, the University of Utah Counseling Center, and Primary Children’s Residential Treatment Center, and has also worked as a medical social worker at the University of Utah Hospital. She has facilitated numerous groups over time and is especially interested in mindfulness and evidence-based treatment models. Kris is member of the National Association of Social Workers, the Association for Contextual and Behavioral Psychology, and the University of Utah College of Social Work Practicum Advisory Committee. She is also a board-certified Diplomate in Clinical Social Work. She has held adjunct faculty positions at the University of Utah College of Social Work, the Department of Clinical Psychology, and the University Medical Center Department of Psychiatry. Volunteer work has included groups at the Cancer Wellness House and psychotherapy services to veterans and their family members through Give An Hour. |
||
Hematology Nurses
Amie Clark, APRN
Renee Vadeboncoeur, APRN
Deirdre Driscoll, RN
Erin Evans, RN
Debbi Green, RN
Mary Vietti, RN
